Filgrastim
| Filgrastim | |
|---|---|
| Term | Filgrastim |
| Short definition | FIHP - A rare inherited disorder in which one or more tumors develop in the parathyroid glands (four pea-sized organs on top of the thyroid gland), causing them to produce too much parathyroid hormone. The increased parathyroid hormone causes a loss of calcium from the bones and too much calcium in the blood. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Filgrastim - (pronounced) (fil-GRAS-tim) A drug used under the brand names Neupogen, Zarxio and Nivestym to treat neutropenia (a lower than normal white blood cell count), prevent infections and to prepare blood for certain types of blood cells to be drawn, and under the brand name Granix, to treat neutropenia. Filgrastim is used in patients with certain types of cancer and neutropenia caused by some types of chemotherapy and in patients with severe chronic neutropenia not caused by cancer treatment. It is also used before an autologous stem cell transplant. Filgrastim helps the bone marrow produce more white blood cells. It's a kind of colony stimulating factor. Also referred to as G-CSF and granulocyte colony stimulating factor
External links
- Medical encyclopedia article on Filgrastim
- Wikipedia's article - Filgrastim
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski